Ligand validation:7DQU

AX7: 1H-benzimidazol-2-amine

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7DQU_AX7_A_301	76%	52%	0.124	0.962	0.99	0.88	-	-	0	0	100%	1
7DQH_AX7_A_301	87%	54%	0.105	0.977	0.92	0.86	-	-	0	0	100%	1
5Z9B_AX7_A_304	87%	51%	0.084	0.955	1.03	0.86	1	-	0	0	100%	1
5Z9E_AX7_B_303	82%	53%	0.113	0.967	1.01	0.82	-	-	0	0	100%	1
7DPR_AX7_A_302	81%	53%	0.101	0.952	0.98	0.86	-	-	0	0	100%	1
5Z4O_AX7_A_305	79%	53%	0.094	0.94	1.02	0.82	-	-	0	0	100%	1
3KQS_AX7_B_290	97%	4%	0.058	0.971	5.32	0.53	8	-	0	0	100%	1
5PAR_AX7_C_506	85%	47%	0.096	0.961	1.31	0.77	1	-	0	0	100%	1
5Z9P_AX7_B_301	84%	52%	0.074	0.936	1	0.88	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.